World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

THE STUDY OF ABNORMAL MENSTRUAL CYCLE FREQUENCY ASSOCIATED WITH THE RAISED BODY MASS INDEX

*Rida Javaid, Hafsa Maryam, Asad Atta Qureshi

ABSTRACT

Objective: This study's main objective was to identify the frequency of menstrual cycle abnormalities associated with higher BMI. Study Design: It is a type of cross-sectional study. Place and Duration of study: This study took place in the Department of Gynecology and Obstetrics in the Nishtar Hospital Multan for nine months from August 2019 to April 2020. Materials and Methods: In the fertile group, a total of 100 cases, i.e. this study included more than 12 years. Menstrual abnormalities were the criteria for inclusion for at least the last three cycles. Exclusion criteria included patients with bleeding trends, utero abnormalities and hormonal abnormalities. The body mass index of each patient was calculated and high BMI patients greater than 25kg/m2 were labelled. There was informed consent from all patients or their relatives. A pre-designed pro forma was used for data collection. The approval of the Ethical Committee has been adopted. Results: For the study, 100 patients were selected. The mean age in our analysis was 20.21±4.57 years. The mean time for menstrual abnormalities was 7.21±2.34 months. 32% of patients had an upgraded BMI. 64 percent took therapy for this. In 16 cases (47.06 percent), the incidence of increased BMI was much higher in patients over 14 years of age with menarche. In 23 cases, patients receiving prior menstrual treatment also had an increased BMI (40.35 percent) (40.35 percent). Conclusion: Elevated BMI and other variables such as delayed menarche and increased menstrual abnormality are positively associated with menstrual abnormalities.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR